Thursday, February 22, 2018

Huge demand has been observed for steam-sterilised spices and herbs in Europe : Ken Research


The report titled “Herbs, Spices & Seasonings (Seasonings, Dressings & Sauces) Market in Europe-Outlook to 2021: Market Size, Growth and Forecast Analytics”, provides a comprehensive analysis herbs, spices and seasonings market in Europe, European consumers convenience towards easy-to-prepare foods, health awareness, demand for herbs, spices and seasonings, demand for ethnic foods, increasing prices of the herbs, spices and seasonings and future of European herbs, spices and seasonings market.

Industry Overview: Herbs, spices and seasonings are various pungent, aromatic plant substances, dried berries such as cinnamon or clove or nutmeg used as whole or ground and added to food for zest and flavour. They also include all dried herbs but exclude fresh herbs, spices and seasonings. The variants in herbs, spices and seasonings are dried herbs, pepper, salt, salt substitutes, single & other spices, spice mixes. The major distribution channel of the herbs, spices and seasonings in Europe are hypermarkets, supermarkets, convenience stores, department stores, dollar stores, variety store, E-retailers, food specialists, health stores, beauty stores, and other general retailers. European consumers are spending less money and less time on preparing meals due to their busy schedules, also the number of single households is increasing rapidly. Consumers are opting for easy-to-prepare and ready-cooked meals that rely on spices and herbs to retain and enhance food flavour. Easy-to-prepare and ready-cooked meals utilize crushed or ground spices, ground herbs, spice mixtures and herb mixtures that are known as ready-to-use spices and herbs. Therefore, there is a demand for processed spices and herbs and the trend will continue over the next few years. Grinding and crushing with improved processing facilities and detection techniques has witnessed a continuing growth over a period of time.
Unhealthy food ingredients such as salt, sugar and synthetic additives are increasingly replaced by natural ingredients such as spices and herbs to promote healthy living. Consumers are expecting clean labelling and gluten-free labelling in the spices and herbs market. It was observed that there is huge demand for steam-sterilised spices and herbs in Europe because these products meet the strict requirements for microbiological contamination. Consumers earn a small premium, if they use steam sterilisation on spices and herbs.
Growing Demand for Herbs, Spices and Seasonings in Europe: The demand for herbs, spices and seasonings in European is increasing due to the health and wellness trends such as healthy living, interest in new tastes and convenience. European consumers are continuously looking for new suppliers due to high prices and scarcity of herbs, spices and seasonings. European herbs, spices and seasonings market majorly focuses on the special varieties, improved quality and sustainability. However, the new players should comply with strict requirements for quality, food safety and traceability to enter the European herbs, spices and seasonings market. It was observed that for a very long time, Europe imports spices and herbs from the developing countries which is a continuing growth. The maturity of the industrial sector has led to a slower than in other sectors, however, herbs, spices and seasonings market will continue to grow. Almost all the Europe’s herbs, spices and seasonings imports are from the developing countries which hold positive market conditions. Herbs, spices and seasonings market is volume-driven with high competition and low margins. The small and medium-sized enterprises have good opportunities in supplying the speciality spices and herbs that are available and traded in smaller volumes. The special varieties of herbs and spices are Mexican chillies and Tellicherry peppercorns. The vendors focus more on speciality product characteristics such as colour, taste, fineness and sustainability.

Growing Popularity of Ethnic Food in Europe: European consumers are demanding for ethnic food due to growing multicultural population within the country. Therefore, there is a huge demand for spices and herbs which are used in exotic cuisine. The popular flavours and tastes in the exotic cuisine are Chinese (pepper, ginger, anise), Indian food (curry, chillies, cardamom), Thai food (cassia cinnamon, cloves, nutmeg), and Vietnamese cuisine (ginger, chillies, fennel, pepper). The consumers are exploring new tastes by cooks and food manufacturers who ensure the market for herbs, spices and seasonings to grow continuously. Small, large, multinational food retailers and specialized brands are focused on ethnic foods coupled with herbs, spices and seasonings market. Smaller processors, retailers and specialised brands demand less of the herbs, spices and seasonings. Such outlets are less demanding in food safety, service and volume. They often import herbs, spices and seasonings from their home country and it is easy to connect with them. The ethnic food tastes vary by region, country and even consumers due to the use of different ingredients and mixes.

Increase in Prices of Herbs, Spices and Seasonings in Europe: It was observed that there is a trend of increasing prices of herbs, spices and seasonings in the European market due to increasing demand and less production. The country, Madagascar is the leading producer of vanilla and the European import prices of vanilla increased significantly over the recent years due to production problems. The future of herbs, spices and seasonings is questionable due to the supply and huge demand. New plantings of spices and herbs will not be able to satisfy the global demand and replenish the low supply levels. Cultivating spices and herbs is a solution to the scarcity problem and the young population is not interested in farming. Spices and herbs are minor but very important ingredients that contribute taste to the food. Europeans demand for herbs and spices is relatively high and unaffected by price changes.

Way Forward in Herbs, Spices and Seasonings in Europe: European requirements of quality, food safety and sustainability are the strictest in the world. Only a small share of the spice and herb are in compliant with European Union requirements. The increase in prices of herbs and spices has also increased fraud causing major concerns for European buyers. The country is continuously looking for suppliers who can meet the strictest requirements to establish long-term relationships along with reliable stock. Few suppliers work directly with farmers to avoid middlemen and such developments offer opportunities in the supply chain of herbs and spices. Europe herbs and spices consumers are attentive towards the responsibility for the social and environmental impact of the business. They are more concerned about child labour, healthy and safe working conditions, respecting labour laws, paying minimum wage and correct use of pesticides. All the herbs and spices leading players such as Unilever, Olam and Verstegen in Europe are collectively working on making the market more sustainable. European consumers are attracted towards convenience, health awareness, demand for ethnic foods and quality of product which tends drive the growth of herbs, spices and seasonings market in the next few years.

Key Topics Covered in the Report:
Europe Herbs, Spices and Seasonings Market Report
Europe Herbs, Spices and Seasonings Market Analysis
Europe Herbs, Spices and Seasonings Market Outlook
Europe Herbs, Spices and Seasonings Variants Market
Europe Herbs, Spices and Seasonings Variants Market Report
Europe Herbs, Spices and Seasonings Variants Market Analysis
Europe Herbs, Spices and Seasonings Variants Market Outlook
Europe Herbs, Spices and Seasonings Market Growth
Europe Dried Herbs Market Report
Europe Dried Herbs Market Analysis
Europe Dried Herbs Market Outlook
Europe Spice Mixes Market Report
Europe Spice Mixes Market Analysis
Europe Spice Mixes Market Outlook
Europe Herbs, Spices and Seasonings Market Value by Brands
Europe Herbs, Spices and Seasonings Market by Distribution Channel
Germany Herbs, Spices and Seasonings Market
Italy Herbs, Spices and Seasonings Market
Spain Herbs, Spices and Seasonings Market
Germany Herbs, Spices and Seasonings Market
Switzerland Herbs, Spices and Seasonings Market

To know more, click on the link below:

https://www.kenresearch.com/food-beverage-and-tobacco/general-food/herbs-spices--seasonings-seasonings-dressings--sauces-market-europe-outlook-market-size-growth-forecast-analytics/143156-11.html

 

Similar Reports:

Contact Us:                                                                                          
Ken Research
Ankur Gupta, Head Marketing & Communications
sales@kenresearch.com
0124-4230204

Lymphangioleiomyomatosis Global Clinical Trials Review H2 2017: Ken Research

GlobalData'sclinical trial report, Lymphangioleiomyomatosis Global Clinical Trials Review, H2, 2017" provides an overview of Lymphangioleiomyomatosis clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphangioleiomyomatosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Lymphangioleiomyomatosis Global Clinical Trials
Global Lymphangioleiomyomatosis Clinical Trials Market Research Report
Global Lymphangioleiomyomatosis Clinical Trials Market Size
Global Lymphangioleiomyomatosis Clinical Trials Market Share
Global Lymphangioleiomyomatosis Clinical Trials Market Outlook
Global Lymphangioleiomyomatosis Clinical Trials Market Trends
Global Lymphangioleiomyomatosis Clinical Trials Market Volume
Europe Lymphangioleiomyomatosis Clinical Trials Market
US Lymphangioleiomyomatosis Clinical Trials Market Revenue
Global Lymphangioleiomyomatosis Clinical Trials Market Forecast

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Global Lyme Disease Clinical Trials Market Research Report: Ken Research

GlobalData'sclinical trial report, Lyme Disease Global Clinical Trials Review, H2, 2017" provides an overview of Lyme Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Lyme Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Lyme Disease Clinical Trials Market Research Report
Global Lyme Disease Clinical Trials Market Size
Global Lyme Disease Clinical Trials Market Outlook
Global Lyme Disease Clinical Trials Market Trends
Global Lyme Disease Clinical Trials Market Volume
Global Lyme Disease Clinical Trials Market Share
Global Lyme Disease Clinical Trials Market Analysis
Global Lyme Disease Clinical Trials Market Growth
Global Lyme Disease Clinical Trials Industry Research
Europe Lyme Disease Clinical Trials Market

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Medical Device Market Indonesia, Medical Device Imports Indonesia, Medical Devices Imports Indonesia : Ken Research


Indonesia Medical device market is almost entirely import driven. The local companies manufacturing is restricted to production of medical consumables and hospital furniture whereas sophisticated medical devices such as diagnostic imaging devices, dental products, orthopedic implants and others are majorly imported from USA, Germany, the Netherlands and Japan.
Indonesia Healthcare market will be facilitated by the rising number of healthcare providers coupled with elevating prevalence of chronic diseases such as diabetes, HIV, Tuberculosis and others. More than 35,000 new beds are likely to be added in Indonesia by 2020.

Prevalence of cardiovascular and oncology diseases coupled with the rising geriatric population base is expected to drive the market for diagnostic imaging products in Indonesia in 2022. Further, investment by international companies along with investment in medical research will bring in advanced devices for better quality of services. The market will witness growing acceptance of 3D imaging techniques among the radiologists and surgeons owing to the benefits such as instrumental manifestations which is not possible with 2D imaging. The imports will increase as demand for advanced clinical laboratory and diagnostics equipment increases which depend heavily on the incidence of diseases related to circulatory problems, diabetes, infections, parasites, and respiratory problems. The government plans to equip community health centers with inpatient facilities and improve their quality of services throughout 34 provinces. This will create further demand for diagnostic imaging devices, auxiliary devices, medical consumables and orthopedic implants in the country.  Aging population is going to impact the demand for orthopedic products and implants and assistive devices market in the positive manner. Rising number of geriatric population will complain about various orthopedic disorders such as arthritis, and osteoporosis, which will subsequently lead to more number of orthopedic procedures, hence elevating the market.
Growing demand for home-use medical devices, expansion of healthcare facilities coupled with rising prevalence of lifestyle and chronic diseases will propel the Indonesia medical device market revenue in future.

Ken Research in its latest study, “Indonesia Medical Devices Market Outlook to 2022 - By Medical Consumable Products, Diagnostic Imaging Products, Auxiliary Devices, Orthopedic Implants, Dental Products, Aesthetic Devices, By Imports & Domestic Production, suggests that demand for medical devices in the market will continue to grow in Indonesia owing to technology advancements and rising number of hospitals and other healthcare facilities.

Key Topics Covered in the Report:
Medical Device Market Indonesia
Medical Consumables Market Indonesia
Type of Medical Devices Indonesia
Medical Device Imports Indonesia
Medical Device Future Trends Indonesia
Trends Indonesia Medical Device Industry
Medical Devices Imports Indonesia
Major Medical Device Manufacturers Indonesia
Major Medical Device Distributors Indonesia
Major International Companies Medical Device Indonesia
Medical Device Competition Parameters
Number of Medical Device Distributors in Indonesia
Type of Medical Consumables in Indonesia
Medical Device Procurement Indonesia
Orthopedic Equipment Market Indonesia
Diagnostic Imaging Industry Indonesia
Medical Consumable Sales Indonesia
Dental Devices Market Indonesia
Competition Orthopedic Devices Indonesia
Market Share Medical Device Indonesia
Future Indonesia Medical Device
Domestic Sales Medical Devices Indonesia
Imported Medical Devices Indonesia
Woundcare Market Indonesia
Syringes, Needles Sales Indonesia
Bandage and Dressings Revenue Indonesia
Suturing Materials Market Indonesia
Ostomy Products Sales Indonesia

For more information on the research report, refer to below link:


Related Reports by Ken Research:


Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Wednesday, February 21, 2018

Indonesia Hospital Market is expected to Reach USD 14 Billion by 2022: Ken Research

Indonesia hospital market segment (by public & private hospitals, by general & specialty hospitals and by region), competitive landscape of major players in the Indonesia hospital market, and covering competitive landscape of major hospitals including Mitra Keluarga Karyasehat Tbk Pt, Siloam Hospitals, PT Sejahteraraya Anugrahjaya, Sarana Meditama, Rumah Sakit Pondok Indah, Surya Husadha General Hospital, Jakarta Eye Center, Rumah Sakit Dr Oen Surakarta, Pertamedika (Rumah Sakit Pusat Pertamina), Kaish Ibu Hospital, Hermina Hospital Group, Awal Bros Hospital Group and Sari Asih. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.
Increase in private hospitals has contributed significantly in the growth of hospital market. High quality of healthcare and less waiting time are the factors contributing to the growth of private hospitals beds.
Siloam Hospitals has the largest hospital network in the country. Public sector hospital has the larger share in terms of number of hospitals in 2017.
Indonesia is expected to observe 1.5 beds per 1,000 people by 2019 with the entry of several private hospital and increase in the capacity of number of beds in the existing ones.
Single specialty or multi-specialty hospitals in the country are planning to invest in advanced medical devices to provide tertiary or super specialty treatment to the patients. For instance, Mandaya Hospital expects to see sharp revenue growth i.e. 30.0% y-o-y rise in 2018 as the hospital will invest in new equipment that should boost demand. The hospital market is expected to rise owing to the government support in the industry. Before 2017 foreigners were only allowed to invest in specialist hospital and, not in general hospitals. However, after the government (through Presidential Regulation No. 44/2016) allowed foreigners to have a maximum stake of 67.0% in general hospitals (for ASEAN investors the maximum figure is 70.0%) FDI has started to rise rapidly. Foreign investments rose from USD 0.2 million in the year 2015 to USD 0.8 million in the year 2016. The foreign investment further increased to USD 14.3 million in the first half of 2017. The market expects higher growth potential in Tier I and Tier II cities due to larger demand supply gap and lower land acquisition cost.
Rising focus on high revenue intensity streams which includes secondary care, tertiary care and quaternary care and comprehensive health screening programs to increase contribution from outpatients coupled with elevating prevalence of chronic and lifestyle diseases will propel the Indonesia hospital market revenue in future. One of the important issues for the hospital market in Indonesia is the lack of qualified physicians and nurses in the hospitals located in the rural areas due to low standard of nursing education in the country.
Ken Research in its latest study, “Indonesia Hospital Market Outlook to 2022 - By Public & Private Hospital, By General & Specialty Hospital, By Region”, suggests that demand for healthcare services in the market will continue to grow in Indonesia owing to favorable government regulations for FDI inflows and rising prominence of health tech startups.
Key Topics Covered in the Report:
Indonesia Hospital Market Size
Indonesia Hospital Market Research
Indonesia Private Hospital Market
Hospitals in Jakarta Area
Number of Public Hospitals Indonesia
Number of Private Hospitals Indonesia
Investment in Hospital Indonesia
For more information on the research report, refer to below link:
Related Reports by Ken Research
Contact:         
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Global Lupus Nephritis Clinical Trials Market Outlook to 2017: Ken Research

GlobalData'sclinical trial report, Lupus Nephritis Global Clinical Trials Review, H2, 2017" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months

Key Topics Covered in the Report:
Global Lupus Nephritis Clinical Trials Market Outlook
Global Lupus Nephritis Clinical Trials Market Size
Global Lupus Nephritis Clinical Trials Market Trends
Global Lupus Nephritis Clinical Trials Market Demand
Global Lupus Nephritis Clinical Trials Market Volume
Global Lupus Nephritis Clinical Trials Market Analysis
Global Lupus Nephritis Clinical Trials Market Forecast
Europe Lupus Nephritis Clinical Trials Market Industry Research
US Lupus Nephritis Clinical Trials Market Revenue
Global Lupus Nephritis Clinical Trials Market Share

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204

Global Lupus Erythematosus Clinical Trials Market Research Report to 2017: Ken Research

GlobalData'sclinical trial report, Lupus Erythematosus Global Clinical Trials Review, H2, 2017" provides an overview of Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using GlobalData'sproprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years

Key Topics Covered in the Report:
Global Lupus Erythematosus Clinical Trials Market Research Report
Global Lupus Erythematosus Clinical Trials Market Size
Global Lupus Erythematosus Clinical Trials Market Trends
Global Lupus Erythematosus Clinical Trials Market Analysis
Global Lupus Erythematosus Clinical Trials Industry Research
Global Lupus Erythematosus Clinical Trials Market Revenue
Global Lupus Erythematosus Clinical Trials Market Forecast
Global Lupus Erythematosus Clinical Trials Market Volume
Global Lupus Erythematosus Clinical Trials Market Demand
Europe Lupus Erythematosus Clinical Trials Market

To know more, click on the link below:

Contact:        
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-124-4230204